A phase I trial of arsenic trioxide in the treatment of infiltrating gliomas of childhood.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Glioma
- Focus Adverse reactions
- 22 Apr 2011 Biomarkers information updated
- 21 Apr 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 21 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.